Delivery Order SPE2DR25D1017-SPE2DR26F9ATV
Award Date 12/3/25
Potential Completion Date 12/4/25
Potential Value $3.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a $46,570.98 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on December 16, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injections. The award, which is not set-aside and issued as a competitive delivery order, is scheduled for completion by December 17, 2025, with fulfillment occurring at the contractor's Conshohocken, Pennsylvania facility. This delivery order represents a continuation of AmerisourceBergen's extensive...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on December 22, 2025, by the Defense Logistics Agency (DLA) for the supply of Zepbound 12.5 mg/0.5 mL pens with a ceiling value of $32,773.68. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 23, 2025, and was competitively awarded with no set-aside designation. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 22, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injections. This firm fixed-price delivery order, valued at $21,693.46, represents a non-competitive set-aside procurement and is scheduled for completion by October 23, 2025. The award will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $38,628.48 delivery order contract by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract utilizes firm fixed pricing and carries an ultimate completion date of August 27, 2025. This award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's broader relationship...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on November 5, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors with a ceiling value of $9,557.24. The award was made under a competitive, non-set-aside basis and carries a firm fixed price structure with an ultimate completion date of November 6, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,042.74 by the Defense Logistics Agency (DLA) for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of December 11, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $10,895.51 by the Defense Logistics Agency (DLA) on December 8, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injections with a completion date of December 9, 2025. The award is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,077.99 by the Defense Logistics Agency (DLA) on December 17, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injections. This competitively awarded, firm fixed-price contract is classified as a child delivery order and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 18, 2025. The award represents a continuation of AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $54,200.70 on December 10, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections. This is a firm fixed-price, competitively awarded contract with a completion date of December 11, 2025, and represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the contractor's Conshohocken, Pennsylvania location,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,459.86 by the Defense Logistics Agency on September 15, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL). The contract is classified as a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and will be performed at the company's location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation applied. This delivery order is...